Leslie Lobel’s research studies the development of a vaccine and cure for infectious diseases, primarily Ebola. Partnering with both the U.S. military and the Uganda Virus Research Institute, his research relies primarily on obtaining and analyzing blood samples from survivors of Ebola and other diseases. Currently, there are over a 100 Ugandan survivors of Ebola that he contacts during his visits, checking their blood antibody and immunity levels over time, trying to discover how their immune system helped them survive. This knowledge is then used to develop monoclonal antibodies for use as a drug which can be manufactured to give people immunity against a number of infectious diseases. This work will provide a “passive” vaccine offering protection immediately after being given.
